Below are the posted goals for the 2023 calendar year, these timelines have been fairly accurate to date and the Phase 3 trial results are to be released in September. The only curve ball is the AAT process and what the next step is. I am cognizant that the details in this process are confidential due to the SP sensitivity. At some point during this process, if both parties cannot agree due to mediation breakdown then the next course of action is court proceedings. I am now wondering if the AAT will be worth pursuing if the Phase 3 are positive............PM?
- Forums
- ASX - By Stock
- FRE
- After approval
FRE
firebrick pharma limited
Add to My Watchlist
14.3%
!
6.0¢

After approval, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
-0.010(14.3%) |
Mkt cap ! $13.47M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.0¢ | $14.43K | 234.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50062 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 1716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50062 | 0.061 |
2 | 214685 | 0.060 |
2 | 30000 | 0.059 |
1 | 100000 | 0.057 |
2 | 143832 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 1716 | 1 |
0.080 | 47101 | 2 |
0.088 | 5758 | 2 |
0.089 | 15000 | 1 |
0.090 | 100 | 1 |
Last trade - 14.40pm 26/06/2025 (20 minute delay) ? |
Featured News
FRE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online